IQVIA is trading 4% up today at $237.42 following a wave of analyst price-target upgrades and broader strength in the healthcare sector.
- Argus, Evercore ISI, HSBC, and Baird have recently raised their price targets, reinforcing confidence in the company’s data-driven model and recurring revenue streams.
- Shares are benefiting from a constructive market backdrop and a firm healthcare tape, despite a lack of new company-specific headlines today.